Geneos Wealth Management’s Eventide US Market ETF ESUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.39M Buy
211,332
+50,825
+32% +$1.55M 0.12% 187
2026
Q2
$4.92M Buy
160,507
+42,328
+36% +$1.22M 0.1% 226
2026
Q1
$3.09M Sell
118,179
-4,753
-4% -$129K 0.07% 286
2025
Q4
$3.31M Buy
122,932
+23,349
+23% +$634K 0.08% 268
2025
Q3
$2.71M Buy
99,583
+3,261
+3% +$86.8K 0.07% 301
2025
Q2
$2.5M Buy
+96,322
New +$2.33M 0.06% 327

Other funds holding ESUM

Geneos Wealth Management's ESUM Position: Q3 2026 in Review

Geneos Wealth Management increased its Eventide US Market ETF (ESUM) stake by 32% in Q3 2026, buying an estimated $1.55M and bringing the position to 211,332 shares worth $6.39M. The position accounts for 0.12% of the portfolio, ranked #187.

Geneos Wealth Management first reported a position in ESUM in Q2 2025 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold ESUM as of Q3 2026.

  • Geneos Wealth Management held 211,332 shares of Eventide US Market ETF worth $6.39M as of Q3 2026.
  • Geneos Wealth Management bought 50,825 Eventide US Market ETF shares in Q3 2026, an estimated $1.55M.
  • Eventide US Market ETF made up 0.12% of Geneos Wealth Management's portfolio in Q3 2026, its #187 holding.
  • Geneos Wealth Management first reported a position in Eventide US Market ETF in Q2 2025 and has held it in 6 quarters since.
  • 50 funds tracked by Wall St. Rank held Eventide US Market ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.